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Background: Behcet’s disease (BD) is a multisystem disease of unknown etiology. There are several clues which
may indicate an ethiopathogenesis role for Helicobacter pylori infection in this disease.
Methods: In a case control study in an out patient department, 48 patients with BD were compared to age, sex
matched controls regarding presence of H. pylori infection by serology and urea breath test (UBT).
Results: Ongoing H. pylori infection was more prevalent among patients with BD using result of UBT with odds
ratio of 3.1 (95% CI: 1.34 – 7.26, PV < 0.001).
Conclusion: H. pylori infection may have a role in the pathogenesis of BD.
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Behcet’s disease is a systemic disease of unknown eti-
ology affecting multiple organs including skin, eye, mu-
cosa of gastrointestinal and genitourinary tract, joints,
endothelial surface of arteries and veins [1].
The disease is most common along the silk route but
has been reported from almost all continents [1,2].
It has clear differences with many other rheumatologic
disorders which have autoimmune basis in their patho-
genesis and the role of environmental factors were con-
sidered prominent in this disease [2-4].
There are several clues which may indicate an ethio-
pathogenesis role for Helicobacter pylori infection in this
disease. This infection is most prevalent in areas where
BD is common [5-7]. The geographic distribution of the
most grave complication of this infection, gastric cancer
have many similarities to BD [8,9].
This study was designed to find any possible relation be-
tween H. pylori infection either current or in past with BD.
Methods
Patients with a definite diagnosis of BD, based on inter-
national study group criteria [10] who were in regular
follow-up for at least one year in Behcet’s disease Clinic* Correspondence: lankaran@sums.ac.ir
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ences, Islamic Republic of Iran, were studied. Clinical
manifestations and organ involvement along with demo-
graphic features were recorded.
For the control group, age and sex matched healthy
asymptomatic people who were referred for routine
check-ups as a part of their regular health surveillance
were studied. Specific questions regarding presence of any
gastrointestinal compliant and/or previous or current his-
tory of gastrointestinal diseases were obtained from both
control and study groups and any subject with positive
history were excluded. Other exclusion criteria in both
cases and controls were: pregnancy, use of proton pump
inhibitor or antibiotics in the past month, any co morbid
condition such as renal failure, liver disease, chronic ob-
structive pulmonary disease, congestive heart failure, age
under 18 or over 65 years.
Anti Helicobacter Pylori antibody IgG were assayed by
ELISA (RADIM, Iran) in both groups. Urea breath test
(UBT) was also done for all cases and controls as described
elsewhere with carbon 14 after overnight fasting and tooth
brushing [11]. If the result of any of these tests were posi-
tive, patients were considered infected with H. pylori.
The study design was approved by the ethics commit-
tee of the Shiraz University of Medical Sciences.
Informed consent from both groups was taken. Odds ra-
tio, with 95% confidence interval Chi Square (Pearson) and
X2 Fisher Exact tests were calculated when appropriate.ral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
Table 1 Demographic features and Helicobacter pylori status of patients with BD and control group
Mean age ± SD Male Serology positive UBT positive Cumulative number of HP infection*
Case 33.2±8.6 17 29 34 37
Controls 32.7±8.8 17 23 20 27
PV NS NS NS < 0.01 < 0.05
*Total number of HP infection when either serology and or UBT were positive.









Positive pathergy test 13 10 0.99 0.22-4.49 0.987
Urogenital ulcers 23 18 1.14 0.30-4.39 0.852
Arthritis 9 8 2.76 0.31-24.89 0.366
Uveitis 12 7 0.28 0.07-1.19 0.084
DVT* 4 3 0.88 0.08-9.44 0.918
Acneiform rash 16 14 2.74 0.52-14.55 0.237
Erythema nodosum 4 3 0.88 0.08-9.44 0.918
*DVT: Deep Vein Thrombosis.
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48 patients (17 males) with BD fulfilled our criteria and
were studied. The same number of healthy people was
enrolled in the control group.
Both groups were comparable regarding mean age and
sex ratio (Table 1).
H. pylori infection as determined by positive UBT was
more prevalent in patients with BD, but the results of
serology were not significantly different between the two
groups.
When a cumulative number of infected patients using
two methods was utilized, the odds ratio for H. pylori
was 2.4026 (95% CI: 0.99 – 5.828, PV: <0.05).
When the result of UBT alone was considered, the ra-
tio was 3.1 (95% CI: 1.34 – 7.26, PV < 0.001).
The odds ratios of H. pylori infection for each major
organ involvement in patients with BD are shown in
Table 2, using a cumulative number of infected patients.
There was only one patient with neurobehcet in this
series who was H. pylori infected, therefore the odds ra-
tio could not be calculated for this manifestation.
Discussion
Despite description of BD for more than 2000 years, the
pathogenesis of this disease is not clear [3,12,13]. Both
genetic and environmental factors are considered to
have ethiopathogentic role in BD [14]. It has been shown
that Turkish immigrants to Germany have higher inci-
dence of BD compared to native Germans but the inci-
dence of BD is much lower than Turkish population
living in Turkey [13,15]. The same pattern is reported
for Japanese immigrants to Hawaii, mainland United
States and south America [13,16].
Among the environmental factors, the role of infec-
tious agents have been proposed [13]. Viral, bacterial,
mycobacterial and even fungal agents have been studied
in these patients with variable results.
Several investigators have studied the role of H. pylori
infection in BD. Almost all of these studies are from
Turkey [17-20]. Avci and colleagues from Turkey prob-
ably were the first group to publish on this issue [17]. In
their serologic case control study, they did not find no
higher prevalence of H. pylori infection in BD compared
to control group but H. pylori eradication in a small
group of their patients resulted in alleviation of symp-
toms. Ersoy and Cakmak and their colleagues in twoother different studies from Turkey could not find any
relation between BD and H. pylori in endoscopic biop-
sies [18,19]. Another group from Turkey reported sig-
nificantly higher prevalence of cytotoxin-associated gene
A positivity in BD [21]. In the latter study prevalence of
anti H. pylori immunoglobulin G antibody was not sig-
nificantly higher in BD which is in concordance to previ-
ous studies but patients’ symptoms improved after H.
pylori eradication like Avci’s report.
Interestingly there are only case reports on association
of H. pylori infection and BD from Japan [22].
In this study from Iran, with a prevalence BD of 80
per 100,000 of inhabitants [7], we found higher preva-
lence of H. pylori infection in patients with BD. This re-
lation was more prominent when result of UBT was
used with OR of 3.1 (95% CI: 1.34 – 7.26, PV < 0.001).
Using serology, there was no significant difference be-
tween case and control group regarding prevalence of H.
pylori infection as was reported by previous researchers.
The reason that serologic evidence of H. pylori infec-
tion was not different between two groups might be re-
lated to the fact that serology can not differentiate
between ongoing infection or previous exposure [23]. It
seems BD has a correlation with ongoing infection, as
even in previous studies who failed to show a correlation
between infection and BD, there were symptomatic im-
provement with H. pylori eradication in those who were
infected [17,21]. Although two previous studies using
endoscopic biopsies were not able to show such a rela-
tion [18,19], but we should note that there are several
intervening factors which may result in false negativity
of endoscopic biopsies for H. pylori infection detection.
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inhibitors and other acid suppressive agents, recent use of
antibiotics among others [23]. In our study we strictly ex-
cluded patients who had factors which could interfere
with result of UBT and this may explain the different
results.
Although the odds ratio for H. pylori infection using
cumulative number of infected patients by both UBT
and serology was 2.4026 with a p value of less than 0.05.
This may be related to relatively small size of our study
group [24].
Whether any specific presentation of BD is related to
H. pylori infection, has been investigated in few studies.
Researchers from Turkey did not find any relation be-
tween deep vein thrombosis and H. pylori infection in
BD [20]. In our own study we could not find statistically
significant correlation between H. pylori infection and
BD manifestations, but it seems the limited number of
our cases have been contributing. Larger studies are
needed to investigate such relation.
The possible mechanism of action of bacterial infec-
tions including H. pylori in the pathogensis of BD may
involve molecular homology of bacterial antigens and
human heat shock protein (HSP) which is now proposed
as the possible antigen in BD [3,4]. This antigen is
expressed outside of cellular membrane in response to
shock and other stresses and physiologic stimuli. Ele-
vated HSP and antibody against this protein have been
shown in sera of patients with BD [25]. The mucosal ex-
pression of HSP was also found to be higher in BD [26].
There is homology between bacterial antigens and
human HSP. Although much of this homology has been
reported for Streptococcus sanguis [27], the same hom-
ology has also been reported for H. pylori [28]. This
would stimulate δγ T cells. This stimulation would be
further augmented with exposure to human HSP and
start a cascade of proinflammatory reactions.Conclusions
In conclusion our study from Iran using UBT could re-
veal a correlation between ongoing H. pylori infection
and BD in contrary to all previous reports which had
some limitations in their methodologies. To find a cor-
relation between H. pylori infection and specific mani-
festations of BD, larger studies are needed.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KBL developed the idea, arranged the logistic for the study, contributed in
data analysis and preparation of manuscript. MRR, MAN, EA and contributed
in data gathering and analysis of data and preparation of the manuscript. AR
contributed to data gathering and preparation of the manuscript. All authors
read and approved the final manuscript.Acknowledgement
This work was supported by a grant from Shiraz University of Medical
Sciences to the corresponding author.
Author details
1Health policy Research Center, Shiraz University of Medical Sciences,
P.O. Box 71345–1414, Shiraz, Islamic Republic of Iran. 2Bushehr
University of Medical Sciences, Bushehr, Islamic Republic of Iran.
3Rheumatology Research Center, Shiraz University of Medical Sciences,
Shiraz, Islamic Republic of Iran.
Received: 20 July 2013 Accepted: 12 March 2014
Published: 31 March 2014
References
1. Davatchi F, Shahram F, Chams-Davatchi C, Shams H, Nadji A, Akhlaghi M,
Faezi T, Ghodsi Z, Faridar A, Ashofteh F, Sadeghi Abdollahi B: Behcet’s
disease: from East to West. Clin Rheumatol 2010, 29:823–833.
2. Mendes D, Correia M, Barbedo M, Vaio T, Mota M, Goncalves O, Valente J:
Behcet’s disease–a contemporary review. J Autoimmun 2009, 32:178–188.
3. Mendoza-Pinto C, Garcia-Carrasco M, Jimenez-Hernandez M, Jimenez
Hernandez C, Riebeling-Navarro C, Nava Zavala A, Vera Recabarren M,
Espinosa G, Jara Quezada J, Cervera R: Etiopathogenesis of Behcet’s
disease. Autoimmun Rev 2010, 9:241–245.
4. Pleyer U, Hazirolan D, Stubiger N: Comments on the pathogenesis of
Behcet’s disease. A key to understanding new therapies? Ophthalmologe
2012, 109(6):563–567. Epub 2012/06/16. Anmerkungen zur Pathogenese des
Morbus Behcet. Ein Schlussel zum Verstandnis neuer Therapien?
5. Tan HJ, Goh KL: Changing epidemiology of Helicobacter pylori in Asia.
J Dig Dis 2008, 9(4):186–189. Epub 2008/10/31.
6. Goh KL, Chan WK, Shiota S, Yamaoka Y: Epidemiology of Helicobacter
pylori infection and public health implications. Helicobacter 2011,
16(Suppl 1):1–9. Epub 2011/09/16.
7. Tonkic A, Tonkic M, Lehours P, Megraud F: Epidemiology and diagnosis
of Helicobacter pylori infection. Helicobacter 2012, 17(Suppl 1):1–8.
Epub 2012/09/14.
8. Fock KM, Ang TL: Epidemiology of Helicobacter pylori infection and
gastric cancer in Asia. J Gastroenterol Hepatol 2010, 25(3):479–486. Epub
2010/04/08.
9. Krejs GJ: Gastric cancer: epidemiology and risk factors. Dig Dis 2010,
28(4–5):600–603. Epub 2010/11/20.
10. Davatchi F: Diagnosis/Classification Criteria for Behcet’s Disease. Patholog
Res Int 2012, 2012:607921. Epub 2011/10/01.
11. Marshall BJ, Plankey MW, Hoffman SR, Boyd CL, Dye KR, Frierson HF Jr,
Guerrant RL, McCallum RW: A 20-minute breath test for helicobacter
pylori. Am J Gastroenterol 1991, 86:438–445.
12. Kaklamani VG, Vaiopoulos G, Kaklamanis PG: Behcet’s Disease. Semin
Arthritis Rheum 1998, 27(4):197–217. Epub 1998/03/26.
13. Galeone M, Colucci R, D’Erme AM, Moretti S, Lotti T: Potential Infectious
Etiology of Behcet’s Disease. Patholog Res Int 2012, 2012:595380.
Epub 2012/01/19.
14. Pineton de Chambrun M, Wechsler B, Geri G, Cacoub P, Saadoun D: New
insights into the pathogenesis of Behcet’s disease. Autoimmun Rev 2012,
11(10):687–698. Epub 2011/12/27.
15. Zouboulis CC, Kotter I, Djawari D, Kirch W, Kohl PK, Ochsendorf FR, Keitel W,
Stadler R, Wollina U, Proksch E, Sohnchen R, Weber H, Gollnick HP, Holzle E,
Fritz K, Licht T, Orfanos CE: Epidemiological features of Adamantiades-
Behcet’s disease in Germany and in Europe. Yonsei Med J 1997,
38:411–422.
16. Hirohata T, Kuratsune M, Nomura A, Jimi S: Prevalence of Behcet’s
syndrome in Hawaii. With particular reference to the comparison of the
Japanese in Hawaii and Japan. Hawaii Med J 1975, 34(7):244–246.
Epub 1975/07/01.
17. Avci O, Ellidokuz E, Simsek I, Buyukgebiz B, Gunes AT: Helicobacter pylori
and Behcet’s disease. Dermatology 1999, 199(2):140–143. Epub 1999/11/13.
18. Cakmak SK, Cakmak A, Gul U, Sulaimanov M, Bingol P, Hazinedaroglu MS:
Upper gastrointestinal abnormalities and Helicobacter pylori in Behcet’s
disease. Int J Dermatol 2009, 48(11):1174–1176. Epub 2010/01/13.
19. Ersoy O, Ersoy R, Yayar O, Demirci H, Tatlican S: H pylori infection in
patients with Behcet’s disease. World J Gastroenterol 2007,
13(21):2983–2985. Epub 2007/06/26.
Lankarani et al. BMC Gastroenterology 2014, 14:58 Page 4 of 4
http://www.biomedcentral.com/1471-230X/14/5820. Senturk O, Ozgur O, Hulagu OS, Canturk NZ, Celebi A, Karakaya AT: Effect of
Helicobacter pylori infection on deep vein thrombosis seen in patients
with Behcet’s disease. East Afr Med J 2006, 83(1):49–51. Epub 2006/04/29.
21. Apan TZ, Gursel R, Dolgun A: Increased seropositivity of Helicobacter
pylori cytotoxin-associated gene-A in Behcet’s disease. Clin Rheumatol
2007, 26(6):885–889. Epub 2006/10/06.
22. Nojima M, Abe T, Igarashi S, Honma T, Oki M, Oikawa H, Matsumoto S,
Nishimura S, Matsunaga T, Yawata A, Kimura H, Takahashi H, Imai K: A case
of gastric mucosal bridge with Behcet’s disease. Nihon Rinsho Meneki
Gakkai Kaishi 2004, 27:177–180.
23. Malfertheiner P, Megraud F, O’Morain CA, Atherton J, Axon AT, Bazzoli F,
Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ:
Management of Helicobacter pylori infection–the Maastricht IV/Florence
Consensus Report. Gut 2012, 61:646–664.
24. Szumilas M: Explaining odds ratios. J Can Acad Child Adolesc Psychiatry
2010, 19(3):227–229.
25. Birtas-Atesoglu E, Inanc N, Yavuz S, Ergun T, Direskeneli H: Serum levels of
free heat shock protein 70 and anti-HSP70 are elevated in Behcet’s
disease. Clin Exp Rheumatol 2008, 26(4 Suppl 50):S96–S98. Epub 2008/11/26.
26. Deniz E, Guc U, Buyukbabani N, Gul A: HSP 60 expression in recurrent oral
ulcerations of Behcet’s disease. Oral Surg Oral Med Oral Pathol Oral Radiol
Endod 2010, 110:196–200.
27. Kaneko F, Oyama N, Yanagihori H, Isogai E, Yokota K, Oguma K: The role of
streptococcal hypersensitivity in the pathogenesis of Behcet’s Disease.
Eur J Dermatol 2008, 18(5):489–498. Epub 2008/08/12.
28. Zhebrun AB, Mukomolov SL, Narvskaia OV: Genotyping and molecular
marking of bacteria and viruses in epidemiological surveillance of
actual infections. Zh Mikrobiol Epidemiol Immunobiol 2011, (4):28–36.
Epub 2011/09/15.
doi:10.1186/1471-230X-14-58
Cite this article as: Lankarani et al.: High prevalence of Helicobacter
pylori infection in Behcet’s disease. BMC Gastroenterology 2014 14:58.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
